Clinical Trial Results:
A randomized, double blind, active controlled, parallel group study to evaluate the effectiveness of valsartan 320 mg in combination with lisinopril 20 mg versus monotherapy with lisinopril 40 mg or valsartan 320 mg in hypertensive patients with microalbuminuria on reduction of urinary albumin creatinine ratio.
Summary
|
|
EudraCT number |
2004-000186-35 |
Trial protocol |
HU |
Global completion date |
31 May 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
07 May 2017
|
First version publication date |
05 Jan 2017
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CVAL489ADE20 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.